The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group.
This study evaluated the impact of province-wide treatment guidelines on consistency of adjuvant therapy for node-negative breast cancer. A retrospective population-based cohort study was conducted in the Canadian provinces of British Columbia, which has province-wide guidelines, and Ontario, which does not. All eligible 1991 incident cases of node-negative breast cancer in British Columbia (n = 942) and a similar number of randomly selected 1991 incident cases in Ontario (n = 938) were reviewed. Consistency of adjuvant therapy received was evaluated by stratifying cases into discrete diagnostic groups using several grouping systems, and by then comparing the distribution of treatments received within each diagnostic group in the two provinces. Recursive partitioning was also performed. We observed that patterns of pathology reporting were consistent with awareness of the factors used in the British Columbia guidelines to define indications for adjuvant therapy. Consistency of care was greater in British Columbia than in Ontario by all diagnostic grouping systems and by recursive partitioning (P
Notes
Cites: J Clin Oncol. 1994 Sep;12(9):1783-88083701
Cites: Health Rep. 1993;5(2):157-778292756
Cites: Qual Health Care. 1995 Mar;4(1):55-6410142039
Cites: J Clin Oncol. 1997 Jan;15(1):216-228996145
Cites: N Engl J Med. 1994 Mar 24;330(12):805-108114832
Cites: J Gen Intern Med. 1986 Sep-Oct;1(5):275-813772615
Cites: J Clin Oncol. 1987 Mar;5(3):504-113819812
Cites: Int J Technol Assess Health Care. 1988;4(1):27-3310287110